Figures and Tables
From the following article:
Cancer-related anemia and recombinant human erythropoietin—an updated overview
Julia Bohlius, Olaf Weingart, Sven Trelle and Andreas Engert
BACK TO ARTICLEFigure 2
Meta-analysis of the relative risk to receive red blood cell transfusions for cancer patients receiving erythropoietin or standard care
Full size and legend (73K)Download Power Point slide (277K)Table 1
Grading of anemia according to the National Cancer Institute classification
Full size and legend Download Power Point slide (230K)Table 2
Effect of recombinant human erythropoietin on hemoglobin response and transfusion rates: FDA license indication studies
Full size and legend Download Power Point slide (292K)Table 3
Effect of recombinant human erythropoietin on hemoglobin response and transfusion rates in randomized controlled trials including published data on >200 patients
Full size and legend Download Power Point slide (466K)
